<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Balanitis and balanoposthitis in children and adolescents: Management</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Balanitis and balanoposthitis in children and adolescents: Management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Balanitis and balanoposthitis in children and adolescents: Management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Matthew Tews, DO</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Laurence S Baskin, MD, FAAP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark I Neuman, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James F Wiley, II, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 16, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4049161942"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>This topic will address the management of balanitis and balanoposthitis in children and adolescents. Clinical manifestations, evaluation, and diagnosis of balanitis and balanoposthitis and routine care of the uncircumcised penis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6483.html" rel="external">"Balanitis and balanoposthitis in children and adolescents: Clinical manifestations, evaluation, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/14539.html" rel="external">"Care and complications of the uncircumcised penis in infants and children"</a>.)</p><p class="headingAnchor" id="H4211821140"><span class="h1">APPROACH</span><span class="headingEndMark"> — </span>When managing a patient with balanitis or balanoposthitis, the physician should first identify and treat urinary obstruction. Subsequent management consists of treating the underlying cause. The therapeutic recommendations below are derived from expert consensus and by clinical experience as well as from guidelines developed for older adolescents and adults [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H3551941801"><span class="h2">Relief of urinary retention</span><span class="headingEndMark"> — </span>Pain may interfere with urination, but true urinary obstruction from balanoposthitis or balanitis complicated by meatitis is unusual. The patient may be able to void after sitting in a bathtub filled with warm water or, alternatively, after application of topical viscous <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>. If these local measures fail, then dorsal penile block (<a class="graphic graphic_figure graphicRef79052" href="/z/d/graphic/79052.html" rel="external">figure 1</a>) and/or procedural sedation, followed by bladder catheterization and prompt pediatric urology consultation, is warranted. If true obstruction occurs or if initial bladder catheterization is unsuccessful, then the patient may undergo dorsal slit procedure or incision of the constricting band of the phimotic foreskin (<a class="graphic graphic_figure graphicRef61427" href="/z/d/graphic/61427.html" rel="external">figure 2</a>) [<a href="#rid2">2</a>]. Circumcision usually follows these emergency procedures once inflammation has subsided.</p><p class="headingAnchor" id="H1973014322"><span class="h2">General measures</span><span class="headingEndMark"> — </span>Regardless of the etiology, proper treatment of balanitis and balanoposthitis requires institution of local care that will reduce inflammation, help prevent future occurrences, and (in uncircumcised patients) reestablish physiologic function of the foreskin:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sitz baths</strong> – Soaking of the penis in warm water containing a weak salt solution two to three times per day is advised while inflammation persists.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoidance of irritants</strong> – In uncircumcised patients, soap should not be used to clean under the foreskin [<a href="#rid3">3</a>]. In both circumcised and uncircumcised patients, the medical provider should counsel the patient and parents/caregivers to avoid exposure of the affected area to bubble bath oils, talc powder, and other irritants. Adolescents should avoid sexual activity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reinforcement of proper foreskin hygiene (patients with balanoposthitis)</strong> – Parents/caregivers should be instructed to clean between the foreskin and glans with a Q-tip and irrigate with clean water regularly until the inflammation resolves [<a href="#rid3">3,4</a>]. For those patients with a tight foreskin or physiologic phimosis, irrigation can be demonstrated by medical personnel with a 5 French or 8 French feeding tube inserted gently into the preputial sulcus [<a href="#rid5">5</a>]. Alternatively, if a feeding tube is not available, the cut tubing of a butterfly needle device may be used, but the clinician should ensure that the cut edge is smooth.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Once inflammation has resolved, regular bathing of the area in clean water should be sufficient. Parents/caregivers should be advised to avoid soap and not to attempt to clean under the foreskin. They should also be counseled to avoid forceful retraction of the foreskin in young, uncircumcised boys. (See  <a class="medical medical_review" href="/z/d/html/14539.html" rel="external">"Care and complications of the uncircumcised penis in infants and children"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Older patients with a fully retractile foreskin should thoroughly but gently clean underneath the prepuce with water and dry the glans penis before returning the foreskin to normal position [<a href="#rid1">1</a>].</p><p></p><p class="headingAnchor" id="H1077934920"><span class="h2">Treatment by etiology</span><span class="headingEndMark"> — </span>Proper treatment of balanitis and balanoposthitis relies on correct diagnosis of the underlying cause. (See  <a class="medical medical_review" href="/z/d/html/6483.html" rel="external">"Balanitis and balanoposthitis in children and adolescents: Clinical manifestations, evaluation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1753314926"><span class="h3">Nonspecific balanitis and balanoposthitis</span><span class="headingEndMark"> — </span>In addition to the general measures described above, empirical application of topical antibiotic ointment (eg, Polysporin or <a class="drug drug_general" data-topicid="9052" href="/z/d/drug information/9052.html" rel="external">Bacitracin</a>) four times daily or <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">mupirocin</a> cream (eg, Bactroban, Bactocin, or Bactoderm) twice daily helps reduce dysuria and may prevent secondary bacterial infection [<a href="#rid5">5</a>]. Ointments that contain <a class="drug drug_general" data-topicid="9686" href="/z/d/drug information/9686.html" rel="external">neomycin</a> may cause contact dermatitis and should be avoided.</p><p class="headingAnchor" id="H3908321212"><span class="h3">Irritant contact balanitis and balanoposthitis</span><span class="headingEndMark"> — </span>This condition is marked by excessive cleansing of the penis or foreskin, often in a patient with atopic dermatitis [<a href="#rid6">6</a>]. Occasionally, irritant contact balanoposthitis results from exposure to a specific allergen. (See  <a class="medical medical_review" href="/z/d/html/1729.html" rel="external">"Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoidance of precipitants</strong> – Any identified precipitants should be avoided, especially soaps. Spermicides and condom lubricants are common culprits in older adolescents.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Application of emollients</strong> – Aqueous creams, such as Keri, Eucerin lotion, or BP (available in the United Kingdom), should be used as a soap substitute after gentle cleansing. The patient or caregiver should <strong>avoid</strong> creams containing parabens preservatives because of potential sensitization and exacerbation of the condition [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1">The clinician should warn sexually active adolescents who are using creams of the potential for condom failure [<a href="#rid1">1</a>].  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Topical corticosteroids</strong> – Low-potency, topical steroids such as <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">hydrocortisone</a> 1 percent cream may be applied sparingly twice daily for one week. Topical steroids are contraindicated in untreated infections or for continuous prophylaxis.</p><p></p><p class="headingAnchor" id="H2193024603"><span class="h3">Fixed drug eruptions</span><span class="headingEndMark"> — </span>These penile or foreskin lesions resolve once the offending medication (tetracyclines, salicylates, phenacetin, phenolphthalein, or sedative hypnotic agent) is discontinued. Topical steroids, such as <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">hydrocortisone</a> 1 percent cream, applied sparingly twice a day for seven days speeds recovery. Severe cases may be treated with an oral course of <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> or <a class="drug drug_general" data-topicid="9808" href="/z/d/drug information/9808.html" rel="external">prednisolone</a> with a tapering dose over 10 to 14 days. Cases associated with Stevens-Johnson syndrome require an intensive approach that addresses the multisystem effects of this disease. (See  <a class="medical medical_review" href="/z/d/html/2089.html" rel="external">"Drug eruptions", section on 'Fixed drug eruption'</a> and  <a class="medical medical_review" href="/z/d/html/2091.html" rel="external">"Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H3117855271"><span class="h3">Traumatic balanitis and balanoposthitis</span><span class="headingEndMark"> — </span>In addition to the general measures described above, empirical application of topical antibiotic ointment (eg, Polysporin or <a class="drug drug_general" data-topicid="9052" href="/z/d/drug information/9052.html" rel="external">Bacitracin</a>) four times daily or cream (eg, Bactroban, Bactocin, or Bactoderm) twice daily to any breaks in the skin helps reduce dysuria and may prevent secondary bacterial infection [<a href="#rid5">5</a>]. Ointments that contain <a class="drug drug_general" data-topicid="9686" href="/z/d/drug information/9686.html" rel="external">neomycin</a> may cause contact dermatitis and should be avoided.</p><p class="headingAnchor" id="H2325146910"><span class="h3">Infectious balanitis and balanoposthitis</span><span class="headingEndMark"> — </span>Proper treatment depends on identifying and treating the source of infection. In young children, the health care provider can start empiric therapy without specific testing based upon history and physical examination in most cases (<a class="graphic graphic_algorithm graphicRef122790" href="/z/d/graphic/122790.html" rel="external">algorithm 1</a>) [<a href="#rid5">5</a>]. Older children and adolescents should have therapy guided by appropriate laboratory studies (<a class="graphic graphic_algorithm graphicRef122791" href="/z/d/graphic/122791.html" rel="external">algorithm 2</a>). (See  <a class="medical medical_review" href="/z/d/html/6483.html" rel="external">"Balanitis and balanoposthitis in children and adolescents: Clinical manifestations, evaluation, and diagnosis", section on 'Further evaluation'</a>.)</p><p class="headingAnchor" id="H1704898615"><span class="h4">Candidal infection</span><span class="headingEndMark"> — </span>In infants, candidal infection of the penis or foreskin usually accompanies diaper dermatitis. Treatment consists of topical antifungal agents (eg, <a class="drug drug_general" data-topicid="9287" href="/z/d/drug information/9287.html" rel="external">clotrimazole</a> or <a class="drug drug_general" data-topicid="9712" href="/z/d/drug information/9712.html" rel="external">nystatin</a>) and other local measures as discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5795.html" rel="external">"Diaper dermatitis"</a>.)</p><p>In older children and adolescents, topical antifungal agents are also the primary therapy. Sexual partners require evaluation and treatment to prevent recurrence. Evaluation for diabetes mellitus is also warranted for all adolescents in whom sexually acquired infection is excluded and for obese, older children at risk for type 2 diabetes mellitus. (See  <a class="medical medical_review" href="/z/d/html/5816.html" rel="external">"Epidemiology, presentation, and diagnosis of type 1 diabetes mellitus in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/5820.html" rel="external">"Epidemiology, presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents"</a>.)</p><p>A single oral dose of <a class="drug drug_general" data-topicid="8450" href="/z/d/drug information/8450.html" rel="external">fluconazole</a> may be used in patients with candidal infection and either diabetes or severe, recurrent infection [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H1859471355"><span class="h4">Dermatophytic infection</span><span class="headingEndMark"> — </span>Treatment for tinea corporis, tinea cruris, or tinea versicolor involving the penis or foreskin is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4030.html" rel="external">"Dermatophyte (tinea) infections", section on 'Tinea corporis'</a> and  <a class="medical medical_review" href="/z/d/html/4030.html" rel="external">"Dermatophyte (tinea) infections", section on 'Tinea cruris'</a> and  <a class="medical medical_review" href="/z/d/html/4039.html" rel="external">"Tinea versicolor (pityriasis versicolor)", section on 'Management'</a>.)</p><p class="headingAnchor" id="H2802021242"><span class="h4">Bacterial infection</span><span class="headingEndMark"> — </span>In young children, proper hygiene in conjunction with empirical application of topical antibiotic ointment (eg, Polysporin or <a class="drug drug_general" data-topicid="9052" href="/z/d/drug information/9052.html" rel="external">Bacitracin</a>) four times daily or <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">mupirocin</a> cream (eg, Bactroban, Bactocin, or Bactoderm) twice daily adequately treats most bacterial balanoposthitis [<a href="#rid5">5</a>]. Ointments that contain <a class="drug drug_general" data-topicid="9686" href="/z/d/drug information/9686.html" rel="external">neomycin</a> may cause contact dermatitis and should be avoided. </p><p>For infections in children with immunocompromise or diabetes mellitus and any child with more extensive infections suggested by fever, lymphadenitis, or degree of swelling and induration that suggests a component of cellulitis, an oral antibiotic such as <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a> may be added in addition to topical therapy.</p><p>Systemic antibiotics are employed to treat group A Streptococcal infection, anaerobic infection, <em>Staphylococcus aureus</em> infection, and sexually transmitted infection as discussed below.</p><p>Sexually transmitted diseases in a prepubertal child strongly indicate sexual abuse and warrant reporting to child protective services and further evaluation [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Presentation'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Group A streptococcal balanoposthitis</strong> – Treatment is the same as for group A streptococcal pharyngitis: oral antibiotics for 10 days. (See  <a class="medical medical_review" href="/z/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anaerobic balanoposthitis</strong> – Common isolates include <em>Gardnerella vaginalis</em> and <em>Bacteroides</em> species. <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">Metronidazole</a> (15 to 35 mg/kg per day in three divided doses) is the most effective treatment for anaerobic infections and should be given in the oral form for one week [<a href="#rid10">10</a>]. Oral <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a> is an alternative. <a class="drug drug_general" data-topicid="8676" href="/z/d/drug information/8676.html" rel="external">Amoxicillin-clavulanate</a> (Augmentin) 80 mg/kg per day (maximum dose: 3 g of <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">amoxicillin</a>) in two to three divided doses for one week is an alternative for infections caused by <em>Bacteroides</em> species but not <em>G. vaginalis</em> infections. Clindamycin cream may be used for mild infections to be applied twice daily until resolved. If sexual transmission is suspected, then the patient's sexual partner(s) should also be screened and treated as indicated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Staphylococcal balanoposthitis</strong> – Children with <em>S. aureus</em> balanoposthitis should receive oral antibiotics that will cover community-acquired methicillin-resistant <em>S. aureus</em> (MRSA) infection. Parenteral therapy is suggested if hospital-acquired MRSA infection is suspected or if the patient is immunocompromised. Therapy should be tailored to pathogen sensitivities once they are available. (See  <a class="medical medical_review" href="/z/d/html/6027.html" rel="external">"Skin and soft tissue infections in children &gt;28 days: Evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gonorrheal balanoposthitis</strong> – Therapy is the same as for gonococcal urethritis. (See  <a class="medical medical_review" href="/z/d/html/15892.html" rel="external">"Treatment of uncomplicated gonorrhea (<i>Neisseria gonorrhoeae </i>infection) in adults and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chlamydial balanoposthitis</strong> – Treatment mirrors that of nongonococcal urethritis. (See  <a class="medical medical_review" href="/z/d/html/7579.html" rel="external">"Treatment of <i>Chlamydia trachomatis</i> infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Syphilitic balanoposthitis</strong> – Management is based on the stage of syphilis. (See  <a class="medical medical_review" href="/z/d/html/7597.html" rel="external">"Syphilis: Treatment and monitoring"</a>.)</p><p></p><p class="headingAnchor" id="H3282055893"><span class="h4">Viral balanoposthitis</span><span class="headingEndMark"> — </span>Genital herpes and genital human papillomavirus (condylomata acuminata) infections may occur through self-inoculation or sexual contact and are difficult to eradicate. Treatment is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8346.html" rel="external">"Treatment of genital herpes simplex virus infection"</a> and  <a class="medical medical_review" href="/z/d/html/8344.html" rel="external">"Prevention of genital herpes virus infections"</a> and  <a class="medical medical_review" href="/z/d/html/99984.html" rel="external">"Condylomata acuminata (anogenital warts): Management of external condylomata acuminata in adult males"</a>.)</p><p class="headingAnchor" id="H1982111828"><span class="h4">Protozoan balanoposthitis</span><span class="headingEndMark"> — </span><em>Trichomonas vaginalis</em> and <em>Entamoeba histolytica</em> balanoposthitis are treated with <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a> [<a href="#rid11">11</a>]. <em>E. histolytica</em> balanoposthitis also requires treatment with a luminal amebicide such as <a class="drug drug_general" data-topicid="9742" href="/z/d/drug information/9742.html" rel="external">paromomycin</a> [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/5453.html" rel="external">"Trichomoniasis: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H3893671178"><span class="h2">Indications for specialty referral</span><span class="headingEndMark"> — </span>The patients with the following presentations warrant referral to a urologist with pediatric expertise for further management [<a href="#rid13">13</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute urinary obstruction</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged or refractory disease course (eg, persistent noninfectious conditions despite several weeks of local care and good hygiene or patients with infectious conditions who have completed a course of targeted antimicrobial treatment without relief of symptoms)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent balanoposthitis or development of true phimosis (scarring with inability to retract the foreskin)</p><p></p><p>In pediatric patients, unresponsive or recurrent balanoposthitis is a potential indication for circumcision. Pathologic evaluation of the prepuce is important to look for balanitis xerotica obliterans [<a href="#rid14">14</a>]. This entity may involve the urethral meatus, may require reconstructive urologic surgery, and is considered precancerous in adults. (See  <a class="medical medical_review" href="/z/d/html/3002.html" rel="external">"Carcinoma of the penis: Epidemiology, risk factors, and pathology"</a>.)</p><p class="headingAnchor" id="H3453042962"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Most patients respond to general care augmented by appropriate topical therapy within seven days. Up to 10 percent of patients have recurrence of balanoposthitis [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H1462461668"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Proper hygiene and avoidance of forceful retraction are the most important interventions to prevent balanoposthitis in young uncircumcised boys. (See  <a class="medical medical_review" href="/z/d/html/14539.html" rel="external">"Care and complications of the uncircumcised penis in infants and children", section on 'Routine care'</a>.)</p><p>Circumcision in the neonatal or postneonatal period as a preventative measure is a controversial topic. Historically, circumcision has been recommended, thinking that it improves genital hygiene, but there are no trial data to support this belief. The presence of a foreskin predisposes to sexually acquired infection (herpes, candidiasis, gonorrhea, syphilis, and human papillomavirus infection), and circumcision reduces the chance of future balanoposthitis [<a href="#rid9">9,15-18</a>]. Circumcision has therefore been used for the treatment as well as the prevention of balanoposthitis [<a href="#rid9">9,16</a>].</p><p>A study in Western Australian boys evaluated the most common reasons for circumcision and found that phimosis, balanoposthitis, and lichen sclerosis (balanitis xerotica obliterans) were the medical causes, in that order of frequency [<a href="#rid19">19,20</a>]. The elective use of circumcision in a patient with recurrent infectious balanoposthitis is reported to be curative but should only be performed after the acute infection has resolved [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H79185212"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/119368.html" rel="external">"Society guideline links: Balanoposthitis"</a>.)</p><p class="headingAnchor" id="H1550196527"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/141185.html" rel="external">"Patient education: Balanitis in children (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/16329.html" rel="external">"Patient education: Care of the uncircumcised penis in babies and children (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2675451602"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach</strong> – When managing a patient with balanitis or balanoposthitis, the clinician should first identify and treat urinary retention. Subsequent management consists of treating the underlying cause. (See <a class="local">'Approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary retention</strong> – True urinary obstruction from balanoposthitis or balanitis complicated by meatitis is unusual. If pain interferes with urination, then the patient will often be able to void after application of topical viscous <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (emergency department or physician's office) or while sitting in a bathtub filled with warm water. (See <a class="local">'Relief of urinary retention'</a> above.) </p><p></p><p class="bulletIndent1">Patients who are still unable to void despite the above measures require dorsal penile block (<a class="graphic graphic_figure graphicRef79052" href="/z/d/graphic/79052.html" rel="external">figure 1</a>) and/or procedural sedation, urgent bladder catheterization, and prompt pediatric urology consultation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General measures</strong> – Proper treatment of balanitis and balanoposthitis in all patients requires institution of local care that will reduce inflammation, help prevent future occurrences, and (in uncircumcised patients) reestablish physiologic function of the foreskin, including (see <a class="local">'General measures'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sitz baths two to three times daily</p><p class="bulletIndent2"><span class="glyph">•</span>Avoidance of irritants such as soap during cleaning, bubble bath oils, and talc powder</p><p class="bulletIndent2"><span class="glyph">•</span>Proper foreskin hygiene as described above</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment by etiology</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonspecific or traumatic balanitis and balanoposthitis</strong> – In addition to general measures, patients with nonspecific or traumatic balanitis and balanoposthitis warrant empirical application of topical antibiotic ointment (eg, Polysporin or <a class="drug drug_general" data-topicid="9052" href="/z/d/drug information/9052.html" rel="external">Bacitracin</a>) four times daily or <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">mupirocin</a> cream (eg, Bactroban, Bactocin, or Bactoderm) twice daily to reduce dysuria and prevent secondary bacterial infection. Ointments that contain <a class="drug drug_general" data-topicid="9686" href="/z/d/drug information/9686.html" rel="external">neomycin</a> may cause contact dermatitis and should be avoided. (See <a class="local">'Nonspecific balanitis and balanoposthitis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Irritant contact balanitis and balanoposthitis</strong> – Treatment of irritant contact balanitis and balanoposthitis includes (see <a class="local">'Irritant contact balanitis and balanoposthitis'</a> above): </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Withdrawal of the precipitating agent (eg, soaps, detergents, spermicides, and condom lubricants).</p><p class="bulletIndent3"><span class="glyph">-</span>Application of aqueous emollient cream.</p><p class="bulletIndent3"><span class="glyph">-</span>Topical, low-potency corticosteroid therapy, such as <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">hydrocortisone</a> 1% cream applied sparingly twice daily for seven days. Topical corticosteroids should only be initiated if the clinician is sure that no concomitant infection exists. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fixed drug eruptions</strong> – Fixed drug eruptions of the penis or foreskin resolve once the offending medication is discontinued. Topical steroids, such as <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">hydrocortisone</a> 1 percent cream, applied sparingly twice daily for seven days speeds recovery. Severe cases may be treated with an oral course of <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> or <a class="drug drug_general" data-topicid="9808" href="/z/d/drug information/9808.html" rel="external">prednisolone</a> with a tapering dose over 10 to 14 days. (See <a class="local">'Fixed drug eruptions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infectious balanitis and balanoposthitis</strong> – Proper treatment of infectious balanitis and balanoposthitis depends on identifying and treating the source of infection. In young children, the health care provider can start empiric therapy without specific testing based upon history and physical examination in most cases (<a class="graphic graphic_algorithm graphicRef122790" href="/z/d/graphic/122790.html" rel="external">algorithm 1</a>). Older children and adolescents should have therapy guided by appropriate laboratory and microbiology studies (<a class="graphic graphic_algorithm graphicRef122791" href="/z/d/graphic/122791.html" rel="external">algorithm 2</a>). (See <a class="local">'Infectious balanitis and balanoposthitis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specialty referral</strong> – The patients with the following presentations warrant referral to a urologist with pediatric expertise for further management (see <a class="local">'Indications for specialty referral'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute urinary obstruction</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prolonged or refractory disease course (eg, persistent noninfectious conditions despite several weeks of local care and good hygiene or patients with infectious conditions who have completed a course of targeted antimicrobial treatment without relief of symptoms)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Recurrent balanoposthitis or development of true phimosis (scarring with inability to retract the foreskin)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Edwards SK, Bunker CB, van der Snoek EM, van der Meijden WI. 2022 European guideline for the management of balanoposthitis. J Eur Acad Dermatol Venereol 2023; 37:1104.</a></li><li><a class="nounderline abstract_t">Thiruchelvam N, Nayak P, Mostafid H. Emergency dorsal slit for balanitis with retention. J R Soc Med 2004; 97:205.</a></li><li class="breakAll">2001 National guideline on the management of balanitis. Edwards S. http://www.bashh.org/guidelines/2002/balanitis_0901b.pdf (Accessed on February 14, 2008).</li><li><a class="nounderline abstract_t">Schwartz RH, Rushton HG. Acute balanoposthitis in young boys. Pediatr Infect Dis J 1996; 15:176.</a></li><li><a class="nounderline abstract_t">Leslie JA, Cain MP. Pediatric urologic emergencies and urgencies. Pediatr Clin North Am 2006; 53:513.</a></li><li><a class="nounderline abstract_t">Birley HD, Walker MM, Luzzi GA, et al. Clinical features and management of recurrent balanitis; association with atopy and genital washing. Genitourin Med 1993; 69:400.</a></li><li class="breakAll">The use of aqueous cream in children with atopic eczema. http://www.eczema.org/aqueous.htm (Accessed on February 15, 2008).</li><li><a class="nounderline abstract_t">Kinghorn GR, Woolley PD. Single-dose fluconazole in the treatment of Candida albicans balanoposthitis. Int J STD AIDS 1990; 1:366.</a></li><li><a class="nounderline abstract_t">Micali G, Nasca MR, Innocenzi D, Schwartz RA. Penile cancer. J Am Acad Dermatol 2006; 54:369.</a></li><li><a class="nounderline abstract_t">Cree GE, Willis AT, Phillips KD, Brazier JS. Anaerobic balanoposthitis. Br Med J (Clin Res Ed) 1982; 284:859.</a></li><li><a class="nounderline abstract_t">Edwards S. Balanitis and balanoposthitis: a review. Genitourin Med 1996; 72:155.</a></li><li class="breakAll">Amebiasis. In: Red Book: 2003 Report of the Committee of infectious diseases, 26th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village 2003. p.193.</li><li class="breakAll">2008 UK National Guideline on the Management of Balanoposthitis. Clinical Effectiveness Group. British Association for Sexual Health and HIV. http://www.bashh.org/documents/2062.pdf. Accessed October 1, 2013</li><li><a class="nounderline abstract_t">Gargollo PC, Kozakewich HP, Bauer SB, et al. Balanitis xerotica obliterans in boys. J Urol 2005; 174:1409.</a></li><li><a class="nounderline abstract_t">Schoen EJ, Colby CJ, To TT. Cost analysis of neonatal circumcision in a large health maintenance organization. J Urol 2006; 175:1111.</a></li><li><a class="nounderline abstract_t">Fakjian N, Hunter S, Cole GW, Miller J. An argument for circumcision. Prevention of balanitis in the adult. Arch Dermatol 1990; 126:1046.</a></li><li><a class="nounderline abstract_t">Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298.</a></li><li><a class="nounderline abstract_t">Morris BJ, Krieger JN. Penile Inflammatory Skin Disorders and the Preventive Role of Circumcision. Int J Prev Med 2017; 8:32.</a></li><li><a class="nounderline abstract_t">Fergusson DM, Lawton JM, Shannon FT. Neonatal circumcision and penile problems: an 8-year longitudinal study. Pediatrics 1988; 81:537.</a></li><li><a class="nounderline abstract_t">Spilsbury K, Semmens JB, Wisniewski ZS, Holman CD. Circumcision for phimosis and other medical indications in Western Australian boys. Med J Aust 2003; 178:155.</a></li><li><a class="nounderline abstract_t">Wiswell TE, Tencer HL, Welch CA, Chamberlain JL. Circumcision in children beyond the neonatal period. Pediatrics 1993; 92:791.</a></li></ol></div><div id="topicVersionRevision">Topic 122239 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36942977" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2022 European guideline for the management of balanoposthitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15056750" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Emergency dorsal slit for balanitis with retention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15056750" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Emergency dorsal slit for balanitis with retention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8822297" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Acute balanoposthitis in young boys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16716794" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pediatric urologic emergencies and urgencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8244363" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clinical features and management of recurrent balanitis; association with atopy and genital washing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8244363" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical features and management of recurrent balanitis; association with atopy and genital washing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2098157" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Single-dose fluconazole in the treatment of Candida albicans balanoposthitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16488287" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Penile cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6121604" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Anaerobic balanoposthitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8707315" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Balanitis and balanoposthitis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8707315" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Balanitis and balanoposthitis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8707315" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Balanitis and balanoposthitis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16145451" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Balanitis xerotica obliterans in boys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16469634" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cost analysis of neonatal circumcision in a large health maintenance organization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2383029" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : An argument for circumcision. Prevention of balanitis in the adult.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19321868" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Male circumcision for the prevention of HSV-2 and HPV infections and syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28567234" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Penile Inflammatory Skin Disorders and the Preventive Role of Circumcision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3353186" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Neonatal circumcision and penile problems: an 8-year longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12580740" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Circumcision for phimosis and other medical indications in Western Australian boys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8233738" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Circumcision in children beyond the neonatal period.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
